Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acne mRNA Vaccine in Mild Acne
NCT07013747Phase 2Recruiting
- Sponsor
- Sanofi
- Start
- Jul 2025
- Primary completion
- Jun 2029
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Acne mRNA vaccine in acne vulgaris, sponsored by Sanofi. Started Jul 2025; status: recruiting.
02
Drugs
Acne mRNA vaccine
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07013747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07013747.